Lifetime Cost-Effectiveness of Structured Education and Exercise Therapy for Knee Osteoarthritis in Australia.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 Oct 2024
Historique:
medline: 1 10 2024
pubmed: 1 10 2024
entrez: 1 10 2024
Statut: epublish

Résumé

Structured education and exercise therapy programs have been proposed to reduce reliance on total knee replacement (TKR) surgery and improve health care sustainability. The long-term cost-effectiveness of these programs is unclear. To estimate the lifetime cost-effectiveness of implementing a national structured education and exercise therapy program for individuals with knee osteoarthritis with the option for future TKR compared with usual care (TKR for all). This economic evaluation used a life table model in combination with a Markov model to compare costs and health outcomes of a national education and exercise therapy program vs usual care in the Australian health care system. Subgroup, deterministic, and probabilistic sensitivity analyses were completed. A hypothetical cohort of adults aged 45 to 84 years who would undergo TKR was created. Structured education and exercise therapy intervention provided by physiotherapists. The comparator was usual care where all people undergo TKR without accessing the program in the first year. Incremental net monetary benefit (INMB), with an incremental cost-effectiveness ratio threshold of 28 033 Australian dollars (A$) per quality-adjusted life-year (QALY) gained, was calculated from a health care perspective. Transition probabilities, costs, and utilities were estimated from national registries and a randomized clinical trial. The hypothetical cohort included 61 394 individuals (53.9% female; 93.6% aged ≥55 years). Implementation of an education and exercise therapy program resulted in a lifetime cost savings of A$498 307 942 (US $339 922 227), or A$7970 (US $5537) per individual, and resulted in fewer QALYs (0.43 per individual) compared with usual care. At a population level, education and exercise therapy was not cost-effective at the lifetime horizon (INMB, -A$4090 [-US $2841]). Subgroup analysis revealed that the intervention was cost-effective only for the first 9 years and over a lifetime only in individuals with no or mild pain at baseline (INMB, A$11 [US $8]). Results were robust to uncertainty around model inputs. In this economic evaluation of structured education and exercise therapy compared with usual care, the intervention was not cost-effective over the lifetime for all patients but was for the first 9 years and for those with minimal pain. These findings point to opportunities to invest early cost savings in additional care or prevention, including targeted implementation to specific subgroups.

Identifiants

pubmed: 39352701
pii: 2824288
doi: 10.1001/jamanetworkopen.2024.36715
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2436715

Auteurs

Sean Docking (S)

School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Zanfina Ademi (Z)

Centre for Medicine Use and Safety, Monash University, Melbourne, Australia.

Christian Barton (C)

La Trobe Sport and Exercise Medicine Research Centre, La Trobe University, Melbourne, Australia.

Jason A Wallis (JA)

School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Cabrini Health, Malvern, Australia.

Ian A Harris (IA)

South West Sydney Campus, School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Liverpool, Australia.

Richard de Steiger (R)

Department of Surgery Epworth Healthcare, The University of Melbourne, Melbourne, Australia.

Rachelle Buchbinder (R)

School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Natasha Brusco (N)

School of Primary and Allied Health Care, Monash University, Melbourne, Australia.

Kirby Young (K)

Cabrini Health, Malvern, Australia.

Marcella Ferraz Pazzinatto (MF)

La Trobe Sport and Exercise Medicine Research Centre, La Trobe University, Melbourne, Australia.

Dylan Harries (D)

South Australian Health and Medical Research Institute, Adelaide, Australia.

Christopher J Vertullo (CJ)

Australian Orthopaedic Association National Joint Replacement Registry, Adelaide, Australia.
Menzies Health Institute, Griffith University, Southport, Australia.

Ilana N Ackerman (IN)

School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH